Lung Cancer Location: a Repository

Lung Cancer Clinical Trial

Official title:

Lung Cancer Location: A Prospective Repository

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00578084
• Other study ID #: 0604-76
• Secondary ID: IRB # 0604-76
• Status: Terminated
• Phase: N/A
• First received: December 19, 2007
• Last updated: October 7, 2013
• Start date: June 2006
• Est. completion date: September 2013

Study information

• Verified date: September 2013
• Source: Indiana University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this repository is to prospectively examine subjects with known or suspected lung cancer to determine the extent of mediastinal lymph node involvement with respect to primary lung cancer location. The data collected in this repository may be used to influence our current standard of care and streamline indications for EUS.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 200
• Est. completion date: September 2013
• Est. primary completion date: July 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Subjects undergoing EUS evaluation of a mediastinal mass, or suspected/known lung cancer

• Subjects with a prior history of lung cancer

• Subjects referred to thoracic surgery for evaluation of a suspected/known lung cancer

Exclusion Criteria:

• Altered mental status that would prohibit the giving and understanding of informed consent

• Dementia

• Psychiatric illness that would preclude adequate compliance with communication for this protocol

• Prisoners

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

Locations

Country	Name	City	State
United States	Clarian/IUPUI: University Hospital	Indianapolis	Indiana

Sponsors (1)

Lead Sponsor	Collaborator
Indiana University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	examine subjects with known or suspected lung cancer to determine the extent of mediastinal lymph node involvement with respect to primary lung cancer location		ongoing-database	No